Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tirzepatide
MedTech
Endoscopic procedure can help slow weight rebound from GLP-1s
A simple outpatient procedure can help those on Eli Lilly’s obesity drug tirzepatide keep most of their weight off when stopping the med.
Ben Adams
Apr 27, 2026 8:48am
How GLP-1s help the heart relax: study
Mar 2, 2026 7:01pm
Novo's CagriSema loses phase 3 obesity battle against Zepbound
Feb 23, 2026 7:20am
Lilly looks to become innovation ‘backbone,’ exec says
Dec 8, 2025 12:05pm
Pfizer’s new prize Metsera touts 14% weight loss for GLP-1
Sep 30, 2025 6:40am
Lilly withdraws phase 2 obesity trial before starting enrollment
Sep 25, 2025 8:07am